YEA CHRISTOPHER (Chief Development Officer) sold 12.8% of their position (33.80K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $905.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/29/2026ACC: 0001691102-26-000007
Officer· Chief Development Officer
Since Sep 2018
-33.80K
Net shares
Net seller
$905.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
33.80K acquired · 67.60K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+33.80K
Price / share
$7.07
Trade value
$238.97K
% of position
14.7%
5/27/2026
229.92K→263.72K
Common Stock
Direct
Shares
−33.80K
Price / share
$26.78
Trade value
$905.22K
% of position
12.8%
5/27/2026
263.72K→229.92K
Total
Net shares
+0.00
Net value
-$666.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/27/2026 | M · Option Exercise | +33.80K | $7.07 | $238.97K | 14.7% | 229.92K | 263.72K |
| Common Stock Direct | 5/27/2026 | S · Sale | −33.80K | $26.78 | $905.22K | 12.8% | 263.72K | 229.92K |
| Total | +0.00 | -$666.26K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
33.80K shares
Shares
−33.80K
Strike price
7.07
Held after
0.00
Exercisable
—
5/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock33.80K shares | 5/27/2026 | M · Option Exercise | −33.80K | 7.07 | — | 0.00 |